GILEAD SCIENCES, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
GILEAD SCIENCES, INC. (GILD) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $17.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $17.00M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $39.00M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was -$111.00M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-03-31 was -$40.00M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month |
|---|---|---|
| 2026-06-30 | $17.00M 10-Q · filed 2026-08-06 | $56.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $39.00M 10-Q · filed 2026-05-07 | |
| 2025-06-30 | -$111.00M 10-Q · filed 2026-08-06 | -$150.00M 10-Q · filed 2026-08-06 |
| 2025-03-31 | -$40.00M 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |